Latest Financials News

Next Science has finalised the sale of nearly all its assets to OSARTIS GmbH for US$50 million, with plans to return approximately US$30 million net proceeds to shareholders following legal and tax review.

Pantera Lithium has won strong shareholder approval for its sale of Daytona Lithium to EnergyX, with due diligence complete and closing expected soon. Meanwhile, Pantera is broadening its US critical minerals portfolio beyond lithium.

Gold Road Resources has announced a fully franked special dividend of $0.43694 per share, contingent on its acquisition by Gold Fields’ Gruyere Holdings. The dividend will reduce the cash consideration payable under the scheme, with the board urging shareholders to approve the deal.

Winchester Energy has farmed out a 30% stake in its Varn waterflood project to a US investor group, unlocking capital and expertise to advance development of over one million barrels of oil equivalent reserves.

New Hope Group’s FY25 results reveal a robust increase in coal production and improved safety, alongside steady shareholder dividends and strategic capital management.

New Hope Corporation reported an 18.1% rise in coal production for FY25 alongside an 8.4% reduction in unit costs, declaring a fully franked 15-cent dividend and launching a Dividend Reinvestment Plan.

New Hope Corporation has updated its 2025 coal resources and reserves, highlighting a significant increase at West Muswellbrook due to a new geological model, while overall reserves remain steady.

New Hope Corporation Limited has unveiled a Dividend Reinvestment Plan (DRP) offering eligible Australian and New Zealand shareholders a flexible, fee-free way to reinvest dividends into additional shares. The plan empowers investors to grow their holdings conveniently while maintaining control over participation levels.

New Hope Corporation Limited has announced a fully franked final dividend of AUD 0.15 per share for FY2025, with a Dividend Reinvestment Plan available to shareholders.

New Hope Corporation Limited posted a slight dip in revenue and net profit for FY2025 but achieved a notable 18% rise in saleable coal production, driven by growth at New Acland Mine and steady output at Bengalla Mine.

CSL Limited has partnered with Dutch biotech VarmX to develop VMX-C001, a novel treatment aimed at reversing bleeding in patients on FXa inhibitors, with FDA Fast Track status and a potential 2029 launch.

Xstate Resources Limited has had its trading suspension lifted as it meets key ASX listing requirements, marking a new chapter for the mining company.